CLINICAL_TRIALS
trial_result
· 2020-02-28
Clinical Trial Update: Beraprost-314d Added-on to Tyvaso® (BEAT) [Phase 3]
Summary
Phase 3 trial BEAT evaluating adding beraprost to Tyvaso in pulmonary arterial hypertension has completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lung Biotechnology PBC | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2020-02-28